Fever, nausea, cramping, and diarrhea — if you have ulcerative colitis (UC), you probably know that those symptoms signal a flare. The same symptoms can also be a Clostridioides difficile (C. diff) ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization, according ...

Altered microbiota and inflammation associated with irritable bowel disease (IBD) appear to make it more difficult for patients to fight off Clostridioides difficile infection, according to a recent ...

Please provide your email address to receive an email when new articles are posted on . Since its introduction in 2011, adoption of diverting loop ileostomy for fulminant Clostridioides difficile ...

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, spoke on antibiotic use and other risk factors for the development of Clostridioides ...

A new study from the University of Birmingham has shown that fecal microbiota transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C. diff) infection. A new ...

Research led by scientists from UCLA and Harvard University has uncovered details about how the bacterium Clostridioides difficile causes excessive inflammation in the gut that can lead to potentially ...

Risk for Clostridioides difficile (C. diff) infection wasn't any greater with vedolizumab (Entyvio) versus anti-tumor necrosis factor (TNF) agents for ulcerative colitis, a researcher reported. In a ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech"), noted that its Founded Entity, Vedanta Biosciences, (“Vedanta”) a late clinical-stage biopharmaceutical company ...

Clostridioides difficileis a major nosocomial pathogen whose virulence depends on toxin production and can be shaped by prophage carriage. Here, we dissect the molecular basis of phi027-dependent ...